Science Explorer Interactive view Map
Topic · Oncology

Chemokine receptors and signaling

Chemokine receptors and signaling is a research topic within Oncology. Science Explorer counts 18k research works in it since 1951. 21.7% of them reached the world's top 10% most cited for their field and year.

This cluster of papers explores the role of chemokine receptors in cancer metastasis, focusing on their involvement in tumor development, immune responses, inflammation, angiogenesis, and cell migration. The research also highlights the potential of chemokine receptors as therapeutic targets in cancer treatment.

  • Chemokine Receptors
  • Cancer Metastasis
  • Chemokines
  • Tumor Development
  • Immune Responses
  • Inflammation
  • Angiogenesis
  • Cell Migration
  • Host Defense
  • Therapeutic Targets
Research works
18k
fractional, since 1951
In the world top 10%
3.8k
per year above
Top-10% rate
21.7%
share of its works in the world top 10%
Growth, 2013–17 → 2018–22
-11%
the tick is no change

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Chemokine receptors and signaling research?

By volume, China and the United States publish the most (719 and 505 works in 2022–2025).

By volume, 2022–2025

  1. 1 China 719 works
  2. 2 United States 505 works
  3. 3 Japan 114 works
  4. 4 Germany 107 works
  5. 5 India 70 works
  6. 6 United Kingdom 62 works
  7. 7 France 62 works
  8. 8 Italy 58 works
  9. 9 South Korea 52 works
  10. 10 Spain 44 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

China: 40.1%United States: 28.2%Japan: 6.4%Germany: 6.0%6 others listed: 19.4%40%largest
China719 · 40.1%United States505 · 28.2%Japan114 · 6.4%Germany107 · 6.0%6 others listed348 · 19.4%

Shares of the rows listed above, not of the whole node.

Which institutions lead Chemokine receptors and signaling research?

By volume in 2022–2025, Tohoku University publishes the most Chemokine receptors and signaling research, followed by Chinese Academy of Medical Sciences & Peking Union Medical College and University of North Carolina at Chapel Hill.

By volume, 2022–2025

  1. 1 Tohoku UniversityJapan 12 works
  2. 2 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 12 works
  3. 3 University of North Carolina at Chapel HillUnited States 11 works
  4. 4 The University of Texas MD Anderson Cancer CenterUnited States 11 works
  5. 5 Sun Yat-sen UniversityChina 10 works
  6. 6 Sichuan UniversityChina 9 works
  7. 7 InsermFrance 8 works
  8. 8 Nanjing Medical UniversityChina 8 works
  9. 9 Shanghai Jiao Tong UniversityChina 7 works
  10. 10 Anhui Medical UniversityChina 7 works

Who are the leading researchers in Chemokine receptors and signaling?

The most-cited researchers publishing on Chemokine receptors and signaling include Alberto Mantovani and Drew M. Pardoll.

  1. 1 Alberto Mantovani Italy 3.6k citations
  2. 2 Drew M. Pardoll United States 2.9k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

Where is Chemokine receptors and signaling research done?

The largest centres of Chemokine receptors and signaling research in 2022–2025 are Beijing (China), Shanghai (China), Guangzhou (China) and Nanjing (China).

Largest cities, 2022–2025

  1. 1 Beijing China 71 works
  2. 2 Shanghai China 60 works
  3. 3 Guangzhou China 51 works
  4. 4 Nanjing China 33 works
  5. 5 Hangzhou China 29 works
  6. 6 Seoul South Korea 28 works
  7. 7 Paris France 28 works
  8. 8 Wuhan China 25 works
  9. 9 Tokyo Japan 24 works
  10. 10 Chengdu China 23 works
See Chemokine receptors and signaling on the map

Where is the best place to study Chemokine receptors and signaling?

Among universities, judged by research, Tohoku University, Chinese Academy of Medical Sciences & Peking Union Medical College and Nanjing Medical University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 22.7667%fractional works in this node (log) →share in the world top 10% →Tohoku University: 12, 7.4%Chinese Academy of Medical Sciences & Peking Union Medical College: 12, 26.1%Nanjing Medical University: 8, 33.7%Sichuan University: 9, 41.9%Sun Yat-sen University: 10, 22.4%University of North Carolina at Chapel Hill: 11, 5.1%Sichuan UniversityNanjing Medical Univ…Chinese Academy of M…Tohoku University
above the meannear itbelow it

One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.

#UniversityScoreTop 10%SpecialisationWorksGrowth
1 Tohoku UniversityJapan 64.57.4%8.4×12 +153.7%
2 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 50.726.1%5.4×12 -14.6%
3 Nanjing Medical UniversityChina 46.433.7%7.4×8 +2.3%
4 Sichuan UniversityChina 42.441.9%2.4×9 +46.0%
5 Sun Yat-sen UniversityChina 28.622.4%2.7×10 +11.5%
6 University of North Carolina at Chapel HillUnited States 26.85.1%2.9×11 +95.8%

Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.

Is Chemokine receptors and signaling research growing?

Output in 2018–2022 was 11% lower than in 2013–2017, peaking in 2025. The fastest-growing topics are Chemokine receptors and signaling.

19801990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.